
Fagron Investor Relations Material
Latest events

H1 2025
Fagron
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fagron NV
Access all reports
Fagron NV is a multinational company that operates within the healthcare sector, specializing in the provision of products and services for pharmaceutical compounding. It supplies a wide range of products, including raw materials, flammable products, extracts and tinctures, anesthetics, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards systems, and consumables. These offerings support the customized preparation of medications to meet specific patient needs, catering to various applications such as allergy, skin care, and hemorrhoids. The company's operations span across Europe, the United States, Brazil, and Argentina, divided into four main segments: Fagron Specialty Pharma Services, Fagron Trademarks, Fagron Essentials, and HL Technology. The company is headquartered in Nazareth, Belgium, and its shares are listed on the Euronext Brussels.
Key slides for Fagron NV


H2 2024
Fagron NV


CMD 2025
Fagron NV
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
FAGR
Country
🇧🇪 Belgium